Stephens & Co. analyst George Sellers reinstates Staar Surgical (NASDAQ:STAA) with a Overweight and announces $91 price target.
Where Sunrun Stands With Analysts
Analysts have provided the following ratings for Sunrun (NASDAQ:RUN) within the last quarter: